Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
Snags $2.2M for Potent Antibody Drugs
7/14/2010 7:42:52 AM
Xconomy -- San Diego-based Femta Pharmaceuticals has pocketed some more venture capital to make targeted antibody drugs that pack more punch.
Lonza Group Ltd.
(LZAGY.PK) Enter into Manufacturing Services Agreement and License for
's GS Gene Expression System(TM)
China Kangtai Cactus Biotech Inc.
Announces $1M Equity Infusion from
Kodiak Capital Group
Reata Pharmaceuticals, Inc.
Completes $78 Million Equity Financing for Second Pivotal Trial of Bardoxolone Methylr
Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
MerLion Pharmaceuticals GmbH
Completes US$7 Million Series C
Announces Financing of $3.15 Million and Board Changes
Metamark Genetics, Inc.
Completes $22 Million Series B Financing to Advance Pipeline of Innovative Function-Based Prognostic Assays for Early Stage Cancers
FDA Adds Liver Failure Warning to Rheumatoid Arthritis Drug
For Drug Design Platform
Alcohol Use Linked to Reduced Arthritis Prevalence
comments powered by Disqus.
comments powered by
Biotech/Pharma - Finance